Acitretin
آسیترتین
🧴 DermatologicalsSystemic retinoid
Market / country: 🇺🇸 USA
Soriatane (US)
🧮 Dose calculator
Psoriasis and steroid-responsive dermatoses · Regimen source: FDA Acitretin · Dosage and Administration
- • Maintenance 25–50 mg by response. Reduce phototherapy dose if combined. Dispense no more than a month at a time. FDA Acitretin · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Pregnancy or intended pregnancy during and for 3 years after; severe hepatic or renal impairment; chronic hyperlipidaemia; concomitant methotrexate (hepatitis); tetracyclines (raised intracranial pressure); alcohol in women (converts to etretinate). FDA Acitretin · ContraindicationsFDA Acitretin · Boxed Warning
Warnings
- • Boxed warning: severe birth defects — women need reliable contraception (two methods) and no alcohol for 3 years after stopping; hepatotoxicity. FDA Acitretin · Boxed Warning
Formulations
- 25 mg capsule — capsule 🇺🇸 USA FDA Acitretin · How Supplied
- 10 mg capsule — capsule 🇺🇸 USA FDA Acitretin · How Supplied
- 17.5 mg capsule — capsule 🇺🇸 USA FDA Acitretin · How Supplied
👥 Special populations
- 🤰 PregnancyContraindicated
Label: contraindicated in pregnancy. FDA Acitretin · CONTRAINDICATIONS
“Pregnancy: S ee boxed CONTRAINDICATIONS AND WARNINGS .”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Acitretin · Nursing Mothers:
“Studies on lactating rats have shown that etretinate is excreted in the milk.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Acitretin · Pediatric Use:
“Safety and effectiveness in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Acitretin · Geriatric Use:
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA204633
- DailyMed (FDA label)FDA Acitretin
- MedlinePlus (NIH)Acitretin
- WHO ATC/DDDD05BB02
- Darooyab (Iran)Acitretin
🇮🇷 Registered in Iran Darooyab · G-2238/Acitretin
Dosage forms with Iranian generic codes, per Darooyab.
- 00017 · ACITRETIN 10MG CAP · کپسول آسیترتین ۱۰ میلیگرم
- 00018 · ACITRETIN 25MG CAP · کپسول آسیترتین ۲۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Acitretin · How SuppliedFDA Acitretin · Dosage and AdministrationFDA Acitretin · ContraindicationsFDA Acitretin · Boxed WarningFDA Acitretin · SPL approval / marketing categoryFDA Acitretin · CONTRAINDICATIONSFDA Acitretin · Nursing Mothers:FDA Acitretin · Pediatric Use:FDA Acitretin · Geriatric Use:
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2238/Acitretin
- Clinical review⚠ Unverified